Sanofi India Ltd. logo

Sanofi India Ltd. (SANOFI)

Market Closed
11 Aug, 22:00
MSE MSE
3,308. 00
-18.2
-0.5472%
- Market Cap
31.06 P/E Ratio
96% Div Yield
87 Volume
262.87 Eps
3,326.2
Previous Close
Add Transaction
Day Range
3,300 3,328.7
Year Range
3,057.6 5,286.45
Want to track SANOFI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SANOFI closed today lower at ₹3,308, a decrease of -0.5472% from yesterday's close, completing a monthly decrease of -2.4088% or -₹81.65. Over the past 12 months, SANOFI stock lost -19.1554%.
SANOFI pays dividends to its shareholders, with the most recent payment made on May 28, 2026. The next estimated payment will be in In 3 months on Nov 28, 2026 for a total of ₹48.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -4.0168%, based on the last three reports.
Sanofi India Ltd. has completed 1 stock splits, with the recent split occurring on Nov 18, 1991.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XNSE (INR).

SANOFI Chart

Sanofi India Ltd. (SANOFI) FAQ

What is the stock price today?

The current price is ₹3,308.00.

On which exchange is it traded?

Sanofi India Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is SANOFI.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 96%.

What is its market cap?

As of today, no market cap data is available.

Has Sanofi India Ltd. ever had a stock split?

Sanofi India Ltd. had 1 splits and the recent split was on Nov 18, 1991.

Sanofi India Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Deepak Arora CEO
MSE Exchange
INE058A01010 ISIN
IN Country
1,097 Employees
- Last Dividend
18 Nov 1991 Last Split
- IPO Date

Overview

Sanofi India Limited is a prominent pharmaceutical company focused on manufacturing and trading a wide range of drugs and pharmaceutical products not only within India but also internationally, extending its reach to renowned markets such as Singapore. The company boasts an expansive portfolio of pharmaceutical products across multiple therapeutic domains including diabetes, cardiology, thrombosis, and more. Originally known as Aventis Pharma Limited, the entity underwent a rebranding to Sanofi India Limited in May 2012, marking a significant milestone in its history. With a foundation laid in 1956, Sanofi India Limited operates with its headquarters positioned in Mumbai, India, functioning under the parent company Hoechst GmbH. Furthermore, the company is known for its active engagement in exporting pharmaceutical products, showcasing its global significance in the pharmaceutical industry.

Products and Services

Sanofi India Limited offers a comprehensive array of pharmaceutical products spanning various therapeutic areas. The company's dedication to healthcare is reflected through its high-quality products, which include:

  • Lantus and Toujeo: Both brands are critical in the management of diabetes, providing patients with cutting-edge insulin treatments.
  • Clexane: A widely recognized brand in the area of thrombosis, offering solutions for blood clot prevention.
  • Amaryl: A trusted name in diabetes care, Amaryl facilitates effective blood sugar regulation.
  • Cardace: Well-regarded in the field of cardiology, Cardace is pivotal in managing high blood pressure and heart failure conditions.
  • Targocid: A vital antibiotic for treating serious infections, thereby playing a crucial role in the anti-infective therapeutic area.
  • Frisium: Catering to the central nervous system, Frisium is aimed at managing epilepsy and seizures.
  • Combiflam: A commonly used anti-inflammatory and analgesic medication, effective for pain relief.
  • DePura: Falling under the vitamins and minerals category, DePura is essential in maintaining overall health and well-being.
  • Allegra and Avil: Both brands are significant in the treatment of allergies, providing relief from allergic symptoms through their antihistamine properties.

These products are distributed through independent channels, ensuring their availability to a wide patient base. Furthermore, Sanofi India Limited's commitment to health extends beyond the domestic market, with a strong focus on exporting its pharmaceutical solutions, thereby contributing significantly to global health advancements.

Contact Information

Address: Sanofi House, Mumbai, India, 400072
Phone: 91 22 2803 2000